Browse > Article
http://dx.doi.org/10.5483/BMBRep.2010.43.6.400

Promoter demethylation mediates the expression of ZNF645, a novel cancer/testis gene  

Bai, Gang (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Liu, Yunqiang (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Zhang, Hao (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Su, Dan (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Tao, Dachang (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Yang, Yuan (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Ma, Yongxin (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Zhang, Sizhong (Division of Human Morbid Genomics, State Key Lab of Biotherapy, P.R.China and Department of Medical Genetics, West China Hospital, Sichuan University)
Publication Information
BMB Reports / v.43, no.6, 2010 , pp. 400-406 More about this Journal
Abstract
Cancer/testis (CT) antigens exhibit highly tissue-restricted expression and are considered promising targets for cancer vaccines. Here we identified a novel CT gene ZNF645 which restrictively expresses in normal human testes and lung cancer patients (68.3%). To investigate the promoter methylation status of ZNF645, we carried out bisulfite genomic sequencing and found that the CpG island in its promoter was heavily methylated in normal lung tissues without the expression of ZNF645, whereas there was high demethylation in normal human testes and lung carcinoma tissues with its expression. Also ZNF645 could be remarkably activated in A549 and HEK293T cells treated by DNA demethylation agent 5'-aza-2'-deoxycytidine. And the dual luciferase assay revealed that the promoter activity of the ZNF645 was inhibited by methylation of the CpG island region. Therefore, we proposed that ZNF645 is a CT gene and activated in human testis and lung cancers by demethylation of its promoter region.
Keywords
Cancer/testis antigen; CpG island; DNA demethylation; ZNF645;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Sasaki, H. and Matsui, Y. (2008) Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat. Rev. Genet. 9, 129-140.   DOI   ScienceOn
2 Jones, P. and Takai, D. (2001) The role of DNA methylation in mammalian epigenetics. Science 293, 1068-1070.   DOI   ScienceOn
3 De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F. and Boon, T. (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. U.S.A. 93, 7149-7153.   DOI   ScienceOn
4 Iguchi-Ariga, S. and Schaffner, W. (1989) CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev. 3, 612-619.   DOI   ScienceOn
5 Coral, S., Sigalotti, L., Altomonte, M., Engelsberg, A., Colizzi, F., Cattarossi, I., Maraskovsky, E., Jager, E., Seliger, B. and Maio, M. (2002) 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications. Clin. Cancer. Res. 8, 2690-2695.
6 Christman, J. (2002) 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 21, 5483-5495.   DOI   ScienceOn
7 James, S., Link, P. and Karpf, A. (2006) Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b. Oncogene. 25, 6975-6985.   DOI   ScienceOn
8 Coral, S., Sigalotti, L., Gasparollo, A., Cattarossi, I., Visintin, A., Cattelan, A., Altomonte, M. and Maio, M. (1999) Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR). J. Immunother 22, 16-24.   DOI
9 Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, New York, USA.
10 Antequera, F. and A. Bird (1993a) CpG islands. EXS. 64, 169-185.
11 Antequera, F. and A. Bird (1993b) Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. U.S.A. 90, 11995-11999.   DOI
12 Dong, X., Yang, X., Wang, Y. and Chen, W. (2004) Zincfinger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients. Br. J. Cancer 91, 1566-1570.   DOI   ScienceOn
13 Loukinov, D., Pugacheva, E., Vatolin, S., Pack, S., Moon, H., Chernukhin, I., Mannan, P., Larsson, E., Kanduri, C., Vostrov, A., Cui, H., Niemitz, E., Rasko, J., Docquier, F., Kistler, M., Breen, J., Zhuang, Z., Quitschke, W., Renkawitz, R., Klenova, E., Feinberg, A., Ohlsson, R., Morse, H. R. and Lobanenkov, V. (2002) BORIS, a novel male germline-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc. Natl. Acad. Sci. U.S.A. 99, 6806-6811.   DOI   ScienceOn
14 Lim, F., Soulez, M., Koczan, D., Thiesen, H. and Knight, J. (1998) A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene. 17, 2013-2018.   DOI
15 Gama-Sosa, M., Slagel, V., Trewyn, R., Oxenhandler, R., Kuo, K., Gehrke, C. and Ehrlich, M. (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic. Acids. Res. 11, 6883-6894.   DOI   ScienceOn
16 del Mazo, J., Prantera, G., Torres, M. and Ferraro, M. (1994) DNA methylation changes during mouse spermatogenesis. Chromosome Res. 2, 147-152.   DOI
17 Zhu, J. and Yao, X. (2007) Use of DNA methylation for cancer detection and molecular classification. J. Biochem. Mol. Biol. 40, 135-141.   DOI
18 Jones, P. and Baylin, S. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428.
19 Hofmann, O., Caballero, O., Stevenson, B., Chen, Y., Cohen, T., Chua, R., Maher, C., Panji, S., Schaefer, U., Kruger, A., Lehvaslaiho, M., Carninci, P., Hayashizaki, Y., Jongeneel, C., Simpson, A., Old, L. and Hide, W. (2008) Genome-wide analysis of cancer/testis gene expression. Proc. Natl. Acad. Sci. U.S.A. 105, 20422-20427.   DOI   ScienceOn
20 Tajima, K., Obata, Y., Tamaki, H., Yoshida, M., Chen, Y., Scanlan, M., Old, L., Kuwano, H., Takahashi, T. and Mitsudomi, T. (2003) Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer 42, 23-33.   DOI   ScienceOn
21 Bird, A. and Wolffe, A. (1999) Methylation-induced repression-belts, braces, and chromatin. Cell. 99, 451-454.   DOI   ScienceOn
22 Cedar, H. (1988) DNA methylation and gene activity. Cell. 53, 3-4.   DOI   ScienceOn
23 Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes. Dev. 16, 6-21.   DOI   ScienceOn
24 Simpson, A., Caballero, O., Jungbluth, A., Chen, Y. and Old, L. (2005) Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 5, 615-625.   DOI   ScienceOn
25 De Smet, C., Lurquin, C., Lethe, B., Martelange, V. and Boon, T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19, 7327-7335.   DOI
26 Grunwald, C., Koslowski, M., Arsiray, T., Dhaene, K., Praet, M., Victor, A., Morresi-Hauf, A., Lindner, M., Passlick, B., Lehr, H., Schäfer, S., Seitz, G., Huber, C., Sahin, U. and Türeci, O. (2006) Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer. Int. J. Cancer 118, 2522-2528.   DOI   ScienceOn
27 van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.   DOI
28 Sigalotti, L., Fratta, E., Coral, S., Tanzarella, S., Danielli, R., Colizzi, F., Fonsatti, E., Traversari, C., Altomonte, M. and Maio, M. (2004) Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine. Cancer Res. 64, 9167-9171.   DOI   ScienceOn
29 Scanlan, M., Gure, A., Jungbluth, A., Old, L. and Chen, Y. (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev. 188, 22-32.   DOI   ScienceOn
30 Scanlan, M., Simpson, A. and Old, L. (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4, 1.
31 Ross, M. and Grafham, D., et al. (2005) The DNA sequence of the human X chromosome. Nature 434, 325-337.   DOI   ScienceOn